Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcuminoids C3 Complex in chronic psoriasis vulgaris
NCT00235625Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Curcuminoids C3 Complex in plaque psoriasis, sponsored by University of Pennsylvania. Primary endpoint: Physicians Global Assessment of Change at 16 weeks. Started Oct 2005; status: completed.
02
Drugs
Curcuminoids C3 Complex
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00235625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235625.